NUVB
NYSE · Pharmaceuticals
Nuvation Bio Inc
$5.71
-0.39 (-6.39%)
Open$6.07
Previous Close$6.10
Day High$6.07
Day Low$5.69
52W High$9.75
52W Low$2.99
Volume—
Avg Volume5.21M
Market Cap2.14B
P/E Ratio—
EPS$-0.44
SectorPharmaceuticals
Analyst Ratings
Strong Buy
18 analysts
Price Target
+656.9% upside
Current
$5.71
$5.71
Target
$43.22
$43.22
$30.63
$43.22 avg
$69.64
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 65.62M | 781.90M | 798.00M |
| Net Income | -213,418,211 | 141.36M | 136.11M |
| Profit Margin | -325.3% | 18.1% | 17.1% |
| EBITDA | -220,400,346 | 195.91M | 227.47M |
| Free Cash Flow | — | 85.45M | 83.04M |
| Rev Growth | — | +23.6% | -6.7% |
| Debt/Equity | 0.68 | 0.84 | 0.71 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,150.99 | -1.64% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.17 | -0.01% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $148.08 | -1.88% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $28.18 | +0.90% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $61.15 | -1.77% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $71.61 | -1.72% | 11.5 | 30.15B |